---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-125833"
form_type: "8-K"
ticker: "VOR"
cik: "0001817229"
company_name: "Vor Biopharma Inc."
filed_at: "2025-05-23T23:59:59+00:00"
generated_at: "2026-05-20T15:05:07.235742+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Vor Biopharma shareholders OK share increase to 800M, re-elect directors

## Summary
- Authorized common shares increased from 400M to 800M; approved by 65.5M votes for vs 7.7M against.
- Class I directors Matthew Patterson and Daniella Beckman re-elected with ~53.4M and ~52.7M votes for.
- Ernst & Young LLP ratified as independent auditor for FY2025 with 73.1M votes for.
- Annual meeting had 73.2M shares represented, ~58.7% of outstanding.

## SEC filing metadata
- accession: 0001193125-25-125833
- form_type: 8-K
- ticker: VOR
- cik: 0001817229
- company_name: Vor Biopharma Inc.
- filed_at: 2025-05-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1817229/000119312525125833/0001193125-25-125833-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1817229/000119312525125833/d95113d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-125833
- JSON: https://secwatch.observer/filing/0001193125-25-125833.json
- Plain text: https://secwatch.observer/filing/0001193125-25-125833.txt

## Key facts
- Governance Changes
  Vor Biopharma Inc.: Increased authorized common stock from 400,000,000 to 800,000,000 shares (effective 2025-05-22).
  - Change: charter amendment
  - Effective: 2025-05-22
  source text: On May 22, 2025, Vor Biopharma Inc. (the “Company”) held its 2025 annual meeting of stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the number of authorized shares of the Company’s common stock (“Common Stock”) from 400,000,000 to 800,000,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1817229/000119312525125833/0001193125-25-125833-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.